Tyrosine kinase inhibitors as a first-line treatment in patients with newly diagnosed chronic myeloid leukemia in chronic phase: A mixed-treatment comparison

Authors :: Ibraheem Yousef
Shahzad Raza
Maria Diab
Rim Hasan
Mohamad Bassam Sonbol
Donald C. Doll
Belal Firwana
Source :: Journal of Clinical Oncology. 32:7054-7054
Publication Year :: 2014
Publisher :: American Society of Clinical Oncology (ASCO), 2014.
Abstract: 7054 Background: Chronic myeloid leukemia (CML) is a myeloproliferative disorder of blood stem cells. After the introduction of tyrosine kinase inhibitors (TKi), patients with CML have had substant...

Subjects :: Cancer Research
business.industry
Treatment comparison
Myeloid leukemia
Newly diagnosed
respiratory tract diseases
First line treatment
Oncology
hemic and lymphatic diseases
Cancer research
Medicine
In patient
Stem cell
business
neoplasms
Tyrosine kinase

Full Text Access

Tools